Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT04792073
Conditions
Merkel Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Avelumab
Comprehensive Ablative Radiation Therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-01. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-04-08.